255 related articles for article (PubMed ID: 31013364)
1. A C-terminal CXCL8 peptide based on chemokine-glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation.
Martínez-Burgo B; Cobb SL; Pohl E; Kashanin D; Paul T; Kirby JA; Sheerin NS; Ali S
Immunology; 2019 Jun; 157(2):173-184. PubMed ID: 31013364
[TBL] [Abstract][Full Text] [Related]
2. The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice.
Vanheule V; Janssens R; Boff D; Kitic N; Berghmans N; Ronsse I; Kungl AJ; Amaral FA; Teixeira MM; Van Damme J; Proost P; Mortier A
J Biol Chem; 2015 Aug; 290(35):21292-304. PubMed ID: 26183778
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.
Gschwandtner M; Strutzmann E; Teixeira MM; Anders HJ; Diedrichs-Möhring M; Gerlza T; Wildner G; Russo RC; Adage T; Kungl AJ
Cytokine; 2017 Mar; 91():65-73. PubMed ID: 28011398
[TBL] [Abstract][Full Text] [Related]
4. Truncation of CXCL8 to CXCL8(9-77) enhances actin polymerization and in vivo migration of neutrophils.
Metzemaekers M; Vandendriessche S; Berghmans N; Gouwy M; Proost P
J Leukoc Biol; 2020 Jun; 107(6):1167-1173. PubMed ID: 32272490
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of the GAG-binding CXCL9(74-103) peptide in dinitrofluorobenzene-induced contact hypersensitivity in mice.
Vanheule V; Crijns H; Poosti F; Ruytinx P; Berghmans N; Gerlza T; Ronsse I; Pörtner N; Matthys P; Kungl AJ; Opdenakker G; Struyf S; Proost P
Clin Exp Allergy; 2018 Oct; 48(10):1333-1344. PubMed ID: 29978510
[TBL] [Abstract][Full Text] [Related]
6. CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration
Vanheule V; Boff D; Mortier A; Janssens R; Petri B; Kolaczkowska E; Kubes P; Berghmans N; Struyf S; Kungl AJ; Teixeira MM; Amaral FA; Proost P
Front Immunol; 2017; 8():530. PubMed ID: 28539925
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs.
Tanino Y; Coombe DR; Gill SE; Kett WC; Kajikawa O; Proudfoot AE; Wells TN; Parks WC; Wight TN; Martin TR; Frevert CW
J Immunol; 2010 Mar; 184(5):2677-85. PubMed ID: 20124102
[TBL] [Abstract][Full Text] [Related]
8. The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions.
Dyer DP; Salanga CL; Johns SC; Valdambrini E; Fuster MM; Milner CM; Day AJ; Handel TM
J Biol Chem; 2016 Jun; 291(24):12627-12640. PubMed ID: 27044744
[TBL] [Abstract][Full Text] [Related]
9. PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation.
Adage T; Del Bene F; Fiorentini F; Doornbos RP; Zankl C; Bartley MR; Kungl AJ
Cytokine; 2015 Dec; 76(2):433-441. PubMed ID: 26303011
[TBL] [Abstract][Full Text] [Related]
10. Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis.
McNaughton EF; Eustace AD; King S; Sessions RB; Kay A; Farris M; Broadbridge R; Kehoe O; Kungl AJ; Middleton J
J Immunol; 2018 May; 200(9):3201-3217. PubMed ID: 29572348
[TBL] [Abstract][Full Text] [Related]
11. TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8.
Dyer DP; Thomson JM; Hermant A; Jowitt TA; Handel TM; Proudfoot AE; Day AJ; Milner CM
J Immunol; 2014 Mar; 192(5):2177-85. PubMed ID: 24501198
[TBL] [Abstract][Full Text] [Related]
12. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
Goldblatt J; Lawrenson RA; Muir L; Dattani S; Hoffland A; Tsuchiya T; Kanegasaki S; Sriskandan S; Pease JE
J Immunol; 2019 Jun; 202(11):3246-3255. PubMed ID: 31010851
[TBL] [Abstract][Full Text] [Related]
13. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
Joseph PRB; Sawant KV; Rajarathnam K
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells.
Derler R; Gesslbauer B; Weber C; Strutzmann E; Miller I; Kungl A
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207576
[TBL] [Abstract][Full Text] [Related]
15. CXCL8 attenuates chemoattractant-induced equine neutrophil migration.
Brooks AC; Rickards KJ; Cunningham FM
Vet Immunol Immunopathol; 2011 Feb; 139(2-4):141-7. PubMed ID: 21040981
[TBL] [Abstract][Full Text] [Related]
16. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
Giblin SP; Ranawana S; Hassibi S; Birchenough HL; Mincham KT; Snelgrove RJ; Tsuchiya T; Kanegasaki S; Dyer D; Pease JE
Front Immunol; 2023; 14():1254697. PubMed ID: 37942327
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase-9-Generated COOH-, but Not NH
Gouwy M; De Buck M; Abouelasrar Salama S; Vandooren J; Knoops S; Pörtner N; Vanbrabant L; Berghmans N; Opdenakker G; Proost P; Van Damme J; Struyf S
Front Immunol; 2018; 9():1081. PubMed ID: 29915572
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
19. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
Crijns H; Vanheule V; Proost P
Front Immunol; 2020; 11():483. PubMed ID: 32296423
[TBL] [Abstract][Full Text] [Related]
20. The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment.
Gangavarapu P; Rajagopalan L; Kolli D; Guerrero-Plata A; Garofalo RP; Rajarathnam K
J Leukoc Biol; 2012 Feb; 91(2):259-65. PubMed ID: 22140266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
